EFFECT OF TREATMENT DURATION ON INCIDENCE OF ADVERSE EVENTS (AES) IN A PHASE III STUDY OF CRIZOTINIB VERSUS CHEMOTHERAPY IN ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
Crizotinib,treatment duration,adverse events,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要